http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0330992-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-553
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-16
filingDate 1989-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1991-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0330992-A3
titleOfInvention Novel cyclobutane derivatives, processes for their preparation and pharmaceutical compositions comprising them
abstract The invention is directed to cyclobutane derivatives nrepresented by general formula (I): n nwherein A represents a hydrogen atom, a hydroxy group, an azido ngroup or an amino group; and B represents a purine residue or a npyrimidine residue. The cyclobutane derivatives exhibit nantiviral and antitumor activities and are thus expected as ndrugs.
priorityDate 1988-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4177348-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0291229-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0159264-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0184473-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157

Total number of triples: 24.